Papers - YAMAMOTO Kenta
-
Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis. Reviewed
Muto H, Ito T, Tanaka T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Maeda K, Honda T, Ishikawa T, Kato A, Ohshiro T, Kano F, Yamamoto A, Sakai K, Hibi H, Ishigami M, Fujishiro M
Scientific reports. Vol. 11 ( 1 ) page： 18778 2021
-
The microbiome can predict mucosal healing in small intestine in patients with Crohn’s disease Reviewed
Shun Hattori, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Yasuyuki Mizutani, Kenta Yamamoto, Takuya Ishikawa, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami, Yoshiki Hirooka Mitsuhiro Fujishiro
Journal of gastroenterology Vol. 55 ( 12 ) page： 1138 - 1149 2020.12
-
The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C Reviewed
Kenta Yamamoto , Takashi Honda , Takanori Ito , Yoji Ishizu , Teiji Kuzuya , Masanao Nakamura , Ryoji Miyahara , Hiroki Kawashima , Masatoshi Ishigami , Mitsuhiro Fujishiro
Journal of Gastroenterology and Hepatology Vol. 36 ( 3 ) page： 790 - 799 2020.8
-
Relationship between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Reviewed
Yamamoto, Kenta, Teiji Kuzuya, Takashi Honda, Takanori Ito, Yoji Ishizu, Masanao Nakamura, Ryoji Miyahara, Hiroki Kawashima, Masatoshi Ishigami, and Mitsuhiro Fujishiro
Anticancer Research Vol. 40 ( 2 ) page： 665–76 2020
-
Microbiota Profile Is Different for Early and Invasive Colorectal Cancer and Is Consistent throughout the Colon. Reviewed
Zorron Cheng Tao Pu, Leonardo, Kenta Yamamoto, Takashi Honda, Masanao Nakamura, Takeshi Yamamura, Shun Hattori, Alastair D. Burt, Rajvinder Singh, Yoshiki Hirooka, and Mitsuhiro Fujishiro.
Journal of Gastroenterology and Hepatology Vol. 35 ( 3 ) page： 433–37 2020
-
Influence of Proton Pump Inhibitors on Microbiota in Chronic Liver Disease Patients. Reviewed
Yamamoto, Kenta, Masatoshi Ishigami, Takashi Honda, Tomoaki Takeyama, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Hidemi Goto, and Yoshiki Hirooka.
Hepatology International Vol. 13 ( 2 ) page： 234–44 2019
-
Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors Reviewed
Yasuda T, Ito T, Ishikawa T, Mizuno K, Yamamoto T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Koshiyama Y, Yasuda S, Toyoda H, Ando Y, Shimoyama Y, Kawashima H.
DIGESTIVE DISEASES AND SCIENCES Vol. 25 page： 38 - 6 2025.1
-
A Proposal for a Simple Subclassification of Advanced Hepatocellular Carcinoma in Systemic Treatment Reviewed
Imai N, Yamamoto T, Mizuno K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Kawashima H.
Cancers Vol. 43 ( 8 ) page： 1855 - 1856 2024.11
-
Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver Disease Reviewed
Inukai Y, Ito T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Shimizu T, Hattori M, Takeyama T, Ando Y, Nishikawa T, Morita K, Toyoda H, Ishigami M, Kawashima H.
Journal of Digestive Diseases Vol. 15 ( 11 ) page： 685 - 693 2024.11
-
Impact of BMI and Body Composition on First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma Reviewed
Yamamoto T, Ito T, Mizuno K, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H.
Anticancer Res Vol. 44 ( 9 ) page： 4101 - 4111 2024.8
-
Predicting early rebleeding and mortality after endoscopic hemostasis of esophagogastric varices: Diagnostic performance of aspartate aminotransferase-to-platelet ratio index and model for end-stage liver disease-Na score Reviewed
Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Nakamura M, Kawashima H.
J Hepatobiliary Pancreat Sci 2024.7
-
Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma Reviewed
Mizuno F, Imai N, Mizuno K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kawashima H.
Anticancer Res Vol. 44 ( 7 ) page： 3185 - 3191 2024.6
-
Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center Reviewed
Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Kojima T, Kariya N, Nakamura M, Kawashima H.
Clin Nutr Vol. 43 ( 6 ) page： 1425 - 1432 2024.5
-
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team Reviewed
Ito T, Mizuno K, Yamamoto T, Yasuda T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Hama M, Kataoka T, Shimokata T, Ando Y, Kawashima H.
Hepatol Res 2024.4
-
A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria Reviewed
Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Muto H, Shirota C, Tainaka T, Sumida W, Makita S, Takada S, Nakagawa Y, Maeda T, Nakamura M, Ishigami M, Uchida H, Kawashima H.
Hepatol Res 2023.10
-
Clinical course and prognosis of patients with hepatocellular carcinoma and haemophilia Reviewed
Matsuda N, Imai N, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Kawashima H.
European Journal of Gastroenterology and Hepatology Vol. 35 ( 10 ) page： 1211 - 1215 2023.8
-
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma Reviewed
Mizuno K, Imai N, Yamamoto T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kuzuya T, Ishigami M, Kawashima H.
Cancers Vol. 21 ( 15 ) page： 2853 2023.6
-
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis Reviewed
Yamamoto T, Mizuno K, Ito T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Ishikawa T, Kanamori A, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Ishii M, Sone M, Ando Y, Akiyama M, Ishigami M, Kawashima H.
Investigational New Drugs Vol. 41 ( 3 ) page： 512 - 521 2023.5
-
Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis Reviewed
Mizuno F, Imai N, Yasuda K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Kawashima H.
Internal Medicine 2023.5
-
Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases Reviewed
Imai N, Ohsaki Y, Cheng J, Zhang J, Mizuno F, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Wake H, Kawashima H.
Scientific Reports Vol. 26 ( 13 ) page： 6851 2023.4